433 related articles for article (PubMed ID: 15350352)
21. Expression of PCNA, p53, Bax, and Bcl-X in oral poorly differentiated and basaloid squamous cell carcinoma: relationships with prognosis.
Sampaio-Góes FC; Oliveira DT; Dorta RG; Nonogaki S; Landman G; Nishimoto IN; Kowalski LP
Head Neck; 2005 Nov; 27(11):982-9. PubMed ID: 16136583
[TBL] [Abstract][Full Text] [Related]
22. Correlation of p53 and Ki-67 (MIB-1) expressions with clinicopathological features and prognosis of early stage cervical squamous cell carcinomas.
Hanprasertpong J; Tungsinmunkong K; Chichareon S; Wootipoom V; Geater A; Buhachat R; Boonyapipat S
J Obstet Gynaecol Res; 2010 Jun; 36(3):572-80. PubMed ID: 20598040
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of Bak expression in oral tongue squamous cell carcinomas.
Xie X; Clausen OP; Boysen M
Oncol Rep; 2003; 10(2):369-74. PubMed ID: 12579274
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma.
Zhang M; Zhang P; Zhang C; Sun J; Wang L; Li J; Tian Z; Chen W
J Oral Pathol Med; 2009 Mar; 38(3):307-13. PubMed ID: 18710422
[TBL] [Abstract][Full Text] [Related]
26. Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas.
Jung JT; Kim DH; Kwak EK; Kim JG; Park TI; Sohn SK; Do YR; Kwon KY; Song HS; Park EH; Lee KB
Ann Hematol; 2006 Sep; 85(9):575-81. PubMed ID: 16673127
[TBL] [Abstract][Full Text] [Related]
27. Expression of apoptosis-regulating proteins p53, Bcl-2, and Bax in primary resected esophageal squamous cell carcinoma.
Hsia JY; Chen CY; Hsu CP; Shai SE; Yang SS; Chuang CY; Wang PY; Chen JT
Neoplasma; 2001; 48(6):483-8. PubMed ID: 11949842
[TBL] [Abstract][Full Text] [Related]
28. [Immunohistochemical study of the predictive value of oncoproteins p53, HER-2 and c-myc during radiotherapy for squamous cell carcinoma of the cervix].
Gasparian NA; Pozharisskiĭ KM; Zharinov GM; Vinokurov VL; Kuznetsova ME; Neklasova NIu
Vopr Onkol; 2007; 53(4):439-44. PubMed ID: 17969407
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis.
Vora HH; Shah NG; Patel DD; Trivedi TI; Chikhlikar PR
J Surg Oncol; 2003 Jan; 82(1):34-50. PubMed ID: 12501167
[TBL] [Abstract][Full Text] [Related]
30. Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis.
Schiller AB; Clark WS; Cotsonis G; Lawson D; DeRose PB; Cohen C
Cytometry; 2002 Aug; 50(4):203-9. PubMed ID: 12210599
[TBL] [Abstract][Full Text] [Related]
31. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
[TBL] [Abstract][Full Text] [Related]
32. The prognostic value of p53, Bcl-2 and Bax expression in laryngeal cancer.
Boonyaphiphat P; Pruegsanusak K; Thongsuksai P
J Med Assoc Thai; 2012 Oct; 95(10):1317-20. PubMed ID: 23193747
[TBL] [Abstract][Full Text] [Related]
33. Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.
Krajewski S; Thor AD; Edgerton SM; Moore DH; Krajewska M; Reed JC
Clin Cancer Res; 1997 Feb; 3(2):199-208. PubMed ID: 9815673
[TBL] [Abstract][Full Text] [Related]
34. Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome.
Tsamandas AC; Kardamakis D; Petsas T; Zolota V; Vassiliou V; Matatsoris T; Kalofonos H; Vagianos CE; Scopa CD
In Vivo; 2007; 21(1):113-8. PubMed ID: 17354623
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
[TBL] [Abstract][Full Text] [Related]
36. Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression.
Jäckel MC; Dorudian MA; Marx D; Brinck U; Schauer A; Steiner W
Cancer; 1999 Feb; 85(3):591-9. PubMed ID: 10091732
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561
[TBL] [Abstract][Full Text] [Related]
38. Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy.
Kang SY; Han JH; Lee KJ; Choi JH; Park JI; Kim HI; Lee HW; Jang JH; Park JS; Kim HC; Kang S; Oh YT; Chun M; Kim JH; Sheen SS; Lim HY
Clin Cancer Res; 2007 Jul; 13(14):4146-53. PubMed ID: 17634542
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma.
Georgiou A; Gomatos IP; Ferekidis E; Syrigos K; Bistola V; Giotakis J; Adamopoulos G; Androulakis G
Eur J Surg Oncol; 2001 Sep; 27(6):574-80. PubMed ID: 11520092
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]